Net Income (Loss) Attributable to Parent in USD of GOLDENWELL BIOTECH, INC. from Q3 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Goldenwell Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2019 to Q2 2025.
  • Goldenwell Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Jun 2025 was -$5.22K, a 89.5% increase year-over-year.
  • Goldenwell Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Jun 2025 was -$90.1K, a 34.3% increase year-over-year.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$131K, a 12% decline from 2023.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$117K, a 88.1% increase from 2022.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$985K, a 742% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

GOLDENWELL BIOTECH, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$90.1K -$5.22K +$44.7K +89.5% 01 Apr 2025 30 Jun 2025 10-Q 12 Sep 2025
Q1 2025 -$135K -$34.4K -$3.32K -10.7% 01 Jan 2025 31 Mar 2025 10-Q 27 May 2025
Q4 2024 -$131K -$27.5K -$6.66K -32% 01 Oct 2024 31 Dec 2024 10-K 15 May 2025
Q3 2024 -$125K -$23.1K +$12.3K +34.9% 01 Jul 2024 30 Sep 2024 10-Q 26 Nov 2024
Q2 2024 -$137K -$49.9K -$22.8K -84.3% 01 Apr 2024 30 Jun 2024 10-Q 12 Sep 2025
Q1 2024 -$114K -$31.1K +$2.55K +7.59% 01 Jan 2024 31 Mar 2024 10-Q 27 May 2025
Q4 2023 -$117K -$20.8K +$900K +97.7% 01 Oct 2023 31 Dec 2023 10-Q 26 Nov 2024
Q3 2023 -$1.02M -$35.4K -$30.8K -672% 01 Jul 2023 30 Sep 2023 10-Q 26 Nov 2024
Q2 2023 -$986K -$27.1K -$284 -1.06% 01 Apr 2023 30 Jun 2023 10-Q 22 Aug 2024
Q1 2023 -$985K -$33.6K -$226 -0.68% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024
Q4 2022 -$985K -$920K -$891K -3015% 01 Oct 2022 31 Dec 2022 10-K 12 Apr 2024
Q3 2022 -$94.3K -$4.58K +$13.2K +74.2% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$107K -$26.8K -$3.22K -13.6% 01 Apr 2022 30 Jun 2022 10-Q 17 Aug 2023
Q1 2022 -$104K -$33.4K +$12.7K +27.6% 01 Jan 2022 31 Mar 2022 10-Q 19 May 2023
Q4 2021 -$117K -$29.5K -$26.6K -893% 01 Oct 2021 31 Dec 2021 10-K/A 06 Feb 2023
Q3 2021 -$90.4K -$17.8K -$16.9K -1920% 01 Jul 2021 30 Sep 2021 10-K/A 06 Feb 2023
Q2 2021 -$73.5K -$23.6K -$23.4K -16626% 01 Apr 2021 30 Jun 2021 10-K/A 06 Feb 2023
Q1 2021 -$50.1K -$46.1K -$43.8K -1879% 01 Jan 2021 31 Mar 2021 10-K/A 06 Feb 2023
Q4 2020 -$6.32K -$2.98K 01 Oct 2020 31 Dec 2020 10-Q 03 Jan 2022
Q3 2020 -$879 +$1.11K +55.8% 01 Jul 2020 30 Sep 2020 10-Q 03 Jan 2022
Q2 2020 -$141 01 Apr 2020 30 Jun 2020 10-Q 02 Dec 2021
Q1 2020 -$2.33K 01 Jan 2020 31 Mar 2020 10-Q 05 Aug 2021
Q3 2019 -$1.99K 01 Jul 2019 30 Sep 2019 10-Q 23 Feb 2021

GOLDENWELL BIOTECH, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$131K -$14.1K -12% 01 Jan 2024 31 Dec 2024 10-K 15 May 2025
2023 -$117K +$868K +88.1% 01 Jan 2023 31 Dec 2023 10-K 15 May 2025
2022 -$985K -$868K -742% 01 Jan 2022 31 Dec 2022 10-K 12 Apr 2024
2021 -$117K -$111K -1750% 01 Jan 2021 31 Dec 2021 10-K 13 Apr 2023
2020 -$6.32K -$4.01K -174% 01 Jan 2020 31 Dec 2020 10-K/A 06 Feb 2023
2019 -$2.31K 01 Jan 2019 31 Dec 2019 10-K 23 Jul 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.